Suppr超能文献

A型肉毒毒素挽救缺血性手部创伤。

Botulinum Toxin A Salvage of Ischemic Hand Trauma.

机构信息

From the Division of Plastic, Reconstructive and Burn Surgery, University of New Mexico.

出版信息

Plast Reconstr Surg. 2020 Jan;145(1):161-164. doi: 10.1097/PRS.0000000000006379.

Abstract

Posttraumatic hand injuries from crush injury, infusion, or iatrogenic vascular cannulation can cause ischemic finger damage that can progress to necrosis and digital amputation. Botulinum toxin type A (Botox) improves blood flow in chronic vasospastic disorders of the hand. Botox's efficacy in salvaging ischemic loss in digits in acute traumatic and iatrogenic injury has not been previously reported. From February of 2015 to December of 2016, 11 patients at a Level I trauma center (West Virginia University) presented to the hand surgery service with early ischemic injury and vascular compromise to hand and fingers as a result of crush, direct drug injection, or proximal arterial injury from drug injection or catheterization. Before 2015, all patients with vascular compromise were treated with standard protocol. After January of 2016, patients were treated with additional injection of 80 to 100 U of Botox into the palm and wrist. Before administration of Botox, six patients with vascular compromise of one or more fingers were treated with a conservative protocol and 83 percent had amputation of necrotic digits. After January of 2016, five patients with ischemia were treated with Botox into the palm and proximal arteries. All Botox-treated digits were preserved (100 percent salvage). Pain scores were lower in Botox-treated fingers. We conclude that (1) in the acute traumatic vascular hand injury, early Botox injection markedly increases digital salvage; (2) direct nerve effects after Botox injections improve postinjury pain scores; and (3) early use of Botox in finger injuries is our standard approach to impending ischemia in the hand.

摘要

创伤后挤压伤、输注或医源性血管插管引起的手部损伤可导致缺血性手指损伤,进而发展为坏死和手指截肢。A型肉毒毒素(Botox)可改善手部慢性血管痉挛性疾病的血流。Botox salvaging 在急性创伤性和医源性损伤中挽救手指缺血损失的疗效以前没有报道过。2015 年 2 月至 2016 年 12 月,西弗吉尼亚大学一级创伤中心的 11 名患者由于挤压、直接药物注射或药物注射或导管插入导致的近端动脉损伤,手部和手指出现早期缺血性损伤和血管功能障碍。在 2015 年之前,所有血管功能障碍的患者均采用标准方案治疗。2016 年 1 月后,患者采用额外注射 80 至 100U Botox 到手掌和手腕进行治疗。在给予 Botox 之前,6 名血管功能障碍的患者接受了一种保守治疗方案,83%的患者因坏死手指而截肢。2016 年 1 月后,5 名手部缺血患者接受了手掌和近端动脉的 Botox 治疗。所有接受 Botox 治疗的手指均得以保留(100%挽救)。Botox 治疗的手指疼痛评分较低。我们的结论是:(1)在急性创伤性手部血管损伤中,早期 Botox 注射明显增加了手指的存活率;(2)Botox 注射后的直接神经作用改善了受伤后的疼痛评分;(3)手部损伤时早期使用 Botox 是我们治疗手部即将发生缺血的标准方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验